RevivBio
PrivateLast Round
Grant
Sep 1, 2024
Total Funding Raised
$3.63M
Momentum Score
50 /100
Company Overview
RevivBio is a biotechnology company that operates a bioengineering and data-driven molecular design platform to develop functional biologics for crop, human, and animal health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, ML Platforms, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevivBio Comps
Public and private peers based on sector, stage, and business model.
RevivBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2024 | ||||
| Accelerator | Apr 2, 2024 | ||||
| Seed | Dec 29, 2023 | ||||
| Debt | Jul 5, 2022 |
RevivBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| gener8tor | Seed |
| BioGenerator Ventures | Seed, Debt |
| Intel Ignite | Accelerator |
| Tet Ventures | Seed |
| Alumni Ventures | Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 11, 2026
Open roles increased to 3, 3x the trailing average.
RevivBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RevivBio's valuation, stock price, and market status.
